6-K - Park Ha Biological Technology Co., Ltd. Ordinary Shares | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Park Ha Biological Technology Co., Ltd. disclosed details of its proposed 1-for-50 reverse stock split of Class A and Class B ordinary shares, which was approved by shareholders on December 26, 2025, and expects the split to become effective on February 20, 2026. The disclosure includes the company's issued and outstanding share capital before and after the proposed reverse split.

Key Takeaways

1The company plans a 1-for-50 reverse stock split of its Class A and Class B ordinary shares.

2Shareholders approved the reverse split at an extraordinary meeting held on December 26, 2025.

3The board of directors approved the exact reverse split ratio on January 29, 2026.

4The reverse split is expected to become effective on February 20, 2026, with trading on a split-adjusted basis beginning at market open that day.

5Pre-split share capital consists of 104,768,362 ordinary shares (85,718,362 Class A, 19,050,000 Class B).

6Post-split share capital is expected to be 2,095,368 ordinary shares (1,714,368 Class A, 381,000 Class B).

7No fractional shares will be issued; all fractional shares will be rounded up to the nearest whole share.

8No other material changes to the terms of the company's securities are anticipated in connection with the reverse split.

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Exhibits (1)

6-K

REPORT OF FOREIGN PRIVATE ISSUER